Dolutegravir and Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution
Determining the interaction of Dolutegravir and Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Dolutegravir and magnesium oxide should not be taken orally at the same time. Products that contain aluminum, calcium, iron, magnesium and/or other minerals may interfere with the absorption of dolutegravir and reduce its effectiveness in treating HIV infection. You should take dolutegravir at least two hours before or six hours after the magnesium oxide dose. Talk to your doctor if you have any questions or concerns, or if you have trouble separating the dosing times. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSING INTERVAL: Coadministration with medications containing polyvalent cations such as aluminum, calcium, iron, or magnesium may decrease the oral bioavailability of dolutegravir. The mechanism of interaction has not been established. In 16 study subjects, administration of a single 50 mg dose of dolutegravir simultaneously with an antacid (Maalox) decreased dolutegravir peak plasma concentration (Cmax), systemic exposure (AUC) and trough plasma concentration (Cmin; 24 hours post-dose) by 72%, 74% and 74%, respectively, compared to administration without the antacid. When the antacid was administered 2 hours after dolutegravir, the Cmax, AUC and Cmin of dolutegravir decreased by just 18%, 26% and 30%, respectively. Administration of single-dose dolutegravir simultaneously with a multivitamin (One-A-Day) decreased the Cmax, AUC and Cmin of dolutegravir by 35%, 33% and 32%, respectively.
MANAGEMENT: Dolutegravir should be administered 2 hours before or 6 hours after medications containing polyvalent cations such as antacids, laxatives, or mineral supplements.
- "Product Information. Tivicay (dolutegravir)." ViiV Healthcare, Research Triangle Park, NC.
Generic Name: citric acid / magnesium oxide / sodium picosulfate
Brand name: Clenpiq, Prepopik
Synonyms: Citric acid, magnesium oxide, and sodium picosulfate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir-Sodium picosulfate, magnesium, and citric acid
- Dolutegravir-Sodium polystyrene sulfonate
- Dolutegravir-Sodium Polystyrene Sulfonate Oral Powder
- Dolutegravir-Sodium Polystyrene Sulfonate Powder
- Dolutegravir-Sodium polystyrene sulfonate Rectal
- Dolutegravir-Sodium Polystyrene Sulfonate Suspension
- Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution-Dolutegravir 10 mg
- Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution-Dolutegravir 25 mg and 50 mg
- Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution-Dolutegravir and lamivudine
- Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution-Dolutegravir and rilpivirine
- Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution-Dolutegravir Sodium
- Sodium Picosulfate, Magnesium Oxide, and Citric Acid Solution-Dolutegravir Sodium And Lamivudine